This bill requires the Department of Health and Human Services (HHS) to negotiate prices for certain drugs (current law prohibits HHS from doing so). Specifically, HHS must negotiate maximum prices for single-source, brand-name drugs that lack certain generics and that are among either the 125 drugs that account for the greatest national spending or the 125 drugs that account for the greatest Medicare spending. HHS must negotiate the prices of at least 25 such drugs for 2024 and of at least 50 such drugs thereafter and must also negotiate prices for certain newly approved drugs and for insulin products. The negotiated prices must be offered under Medicare and may also be offered under private health insurance unless the insurer opts out.

This bill was introduced in the House by Representative Frank Pallone (D-NJ) on 04/22/2021.

ACTION REQUEST | Ask your Member of Congress and Senators to: 

  • Support the Elijah E. Cummings Lower Drug Costs Now Act, especially if they serve on the Energy and Commerce; Ways and Means; Education and Labor; Oversight and Reform; Veterans' Affairs committees.
  • Introduce it in the Senate.
  • To co-sponsor, if they are not doing so already.
    • Thank them for their co-sponsorship, if they are already a co-sponsor.
  • Share your own or your family member’s experience with drug costs.

TALKING POINTS:

  • Prescription drug prices are rising beyond the means of many who need them. This includes drugs that many the LGBTQ+ community rely upon, such as HIV medication and PrEP. 
  • Medicare is currently forbidden from negotiating lower drug prices. The Elijah E. Cummings Lower Drug Costs Now Act would change that.